Premium
Advanced intravital subcellular imaging reveals vital three‐dimensional signalling events driving cancer cell behaviour and drug responses in live tissue
Author(s) -
Nobis Max,
Carragher Neil O.,
McGhee Ewan J.,
Morton Jennifer P.,
Sansom Owen J.,
Anderson Kurt I.,
Timpson Paul
Publication year - 2013
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/febs.12348
Subject(s) - intravital microscopy , disease , neuroscience , drug action , drug discovery , process (computing) , drug , drug development , biology , in vivo , medicine , pathology , computer science , bioinformatics , pharmacology , microbiology and biotechnology , operating system
The integration of signal transduction pathways plays a fundamental role in governing disease initiation, progression and outcome. It is therefore necessary to understand disease at the signalling level to enable effective treatment and to intervene in its progression. The recent extension of in vitro subcellular image‐based analysis to live in vivo modelling of disease is providing a more complete picture of real‐time, dynamic signalling processes or drug responses in live tissue. Intravital imaging offers alternative strategies for studying disease and embraces the biological complexities that govern disease progression. In the present review, we highlight how three‐dimensional or live intravital imaging has uncovered novel insights into biological mechanisms or modes of drug action. Furthermore, we offer a prospective view of how imaging applications may be integrated further with the aim of understanding disease in a more physiological and functional manner within the framework of the drug discovery process.